Bio-Rad's CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing

Strategies to overcome common qPCR challenges

Implement a scalable platform to simultaneously track all lab instruments’ performance.

Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results.

An expanded, high-quality chemical library provides efficient hit series identification of drug candidates.

An overview of the power and flexibility of live-cell analysis

A new webinar series provides a platform for life scientists and molecular biologists to share their cutting-edge research.

How single-cell secretomic analysis revealed the role of TEMRA CD8⁺ T cells in kidney transplant rejection.

Eunsin Bae, M.D discusses multiplex testing and the benefits of Seegene’s Allplex™ SARS-CoV-2/FluA/FluB/ RSV Assay 

Scientists combine microplate readers and cell-based assays for high throughput and reduced variability across a variety of applications.

A guide to biochemical assays for measuring drug-target interactions

Automation and digital connectivity modernize and streamline cell therapy manufacturing. 

Discover the latest research and advances in nanoparticle technology. 

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates. 

Novel RNA Seq-based technology offers unbiased profiling of all seven human TCR and BCR
variable regions from a single sample

Premier Life Sciences Innovator Delivers Groundbreaking Cellular Analysis Technology